Showing 1-10 of 13 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| A multiorgan autoimmune T-cell killing in-vitro platform to improve T1D drug screening | Indiana Biosciences Research Institute | Roberto Mallone | Cures | 01-June-2026 to 31-May-2027 | $196,040.47 |
| Exploiting SDF2L1 to protect against beta cell death and dysfunction in T1D | Indiana Biosciences Research Institute | Michael Kalwat | Cures | 01-December-2024 to 30-November-2027 | $748,169.00 |
| CGM-Derived Glucose Dynamic Index as Diagnostic Marker for Progression to Type 1 Diabetes | Trustees of Indiana University | Viral Shah | Cures | 01-November-2024 to 31-October-2027 | $900,000.00 |
| Safety and Efficacy of Adjunct Therapies in Adults with Type 1 diabetes: multicenter, registry-based study | Trustees of Indiana University | Viral Shah | Improving Lives | 01-September-2025 to 31-August-2028 | $1,603,777.39 |
| Design of Pump-Compatible Insulin-Glucagon Fusion Proteins | Trustees of Indiana University | Michael Weiss | Improving Lives | 01-April-2026 to 31-March-2027 | $255,749.24 |
| SOLUBLE LYMPHOCYTE ACTIVATION GENE-3 (s-LAG-3): A POTENTIAL SURROGATE MARKER FOR TYPE-1 DIABETES PROGRESSION AND IMMUNOTHERAPY SUCCESS | Trustees of Indiana University | Jon Piganelli | Cures | 01-July-2025 to 30-June-2026 | $153,000.00 |
| Type I Interferons and B Cell Metabolism as Drivers of Type 1 Diabetes | Trustees of Indiana University | Jamie Felton | Cures | 01-February-2026 to 31-January-2029 | $682,534.00 |
| Role of ZBED3 in beta cell stress response and vulnerability against autoimmunity | Trustees of Indiana University | Erica Cai | Cures | 01-June-2026 to 29-February-2028 | $383,433.16 |
| Optimizing Approaches to Type 1 Diabetes Prediction and Intervention in the Adult Autoantibody Positive Population | Trustees of Indiana University | Emily Sims | Cures | 01-February-2026 to 31-January-2029 | $691,694.00 |
| Targeting type 1 Diabetes through Polyamines with DFMO | Trustees of Indiana University | Emily Sims | Cures | 01-October-2022 to 30-September-2027 | $3,693,701.00 |